T. Fox, G. Oliver, and S. Ellis, The Destructive Capacity of Drug Abuse: An Overview Exploring the Harmful Potential of Drug Abuse Both to the Individual and to Society, ISRN Addiction, vol.106, issue.3, supplement e33, 2013.
DOI : 10.1542/peds.2009-0637

C. Kilts, J. Schweitzer, C. Quinn, R. Gross, T. Faber et al., Neural Activity Related to Drug Craving in Cocaine Addiction, Archives of General Psychiatry, vol.58, issue.4, pp.334-375, 2001.
DOI : 10.1001/archpsyc.58.4.334

URL : http://archpsyc.jamanetwork.com/data/journals/psych/11816/yoa9048.pdf

E. Zurbach, Phénomènes émergents liés aux drogues en 2015 Tendances récentes sur le site de Marseille, AMPTA, vol.51, 2016.

J. Kim and A. Lawrence, Drugs currently in Phase II clinical trials for cocaine addiction, Expert Opinion on Investigational Drugs, vol.51, issue.8, pp.1105-1127, 2014.
DOI : 10.1007/s40263-014-0142-x

B. Indave, S. Minozzi, P. Pani, and L. Amato, Antipsychotic medications for cocaine dependence, 2016.
DOI : 10.1192/bjp.133.5.429

D. Richard, J. Senon, and M. Valleur, Dictionnaire des drogues et des dépendances Paris: Larousse, 2009.

L. Karila, Le dictionnaire des addictions, Paris: Phase, vol.5, 2006.

V. Deroche-gamonet, D. Belin, and P. Piazza, Evidence for Addiction-like Behavior in the Rat, Science, vol.305, issue.5686, pp.1014-1021, 2004.
DOI : 10.1126/science.1099020

P. Kopp, Le coût social des drogues en France, Tend OFDT, 2015.

C. Melman and J. Lebrun, L'homme sans gravité: jouir à tout prix. Paris: Denoël, 2009.

J. Anthony, L. Warner, and R. Kessler, Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey., Experimental and Clinical Psychopharmacology, vol.2, issue.3, p.244, 1994.
DOI : 10.1037/1064-1297.2.3.244

. Observatoire-français-des-drogues-et-des-toxicomanies and M. Pousset, Drogues et addictions, données essentielles. Saint-Denis La Plaine: Observatoire français des drogues et des toxicomanies, 2013.

G. Koob, L. Moal, and M. , Drug Addiction, Dysregulation of Reward, and Allostasis, Neuropsychopharmacology, vol.24, issue.2, pp.97-129, 2001.
DOI : 10.1016/S0893-133X(00)00195-0

URL : http://www.nature.com/npp/journal/v24/n2/pdf/1395603a.pdf

. American-psychiatric-association, Diagnostic and statistical manual of mental disorders: DSM-5. 5, 2013.
DOI : 10.1176/appi.books.9780890425596

G. Koob and F. Bloom, Cellular and molecular mechanisms of drug dependence, Science, vol.242, issue.4879, pp.715-738, 1988.
DOI : 10.1126/science.2903550

N. Volkow, J. Fowler, G. Wang, and R. Goldstein, Role of Dopamine, the Frontal Cortex and Memory Circuits in Drug Addiction: Insight from Imaging Studies, Neurobiology of Learning and Memory, vol.78, issue.3, pp.610-634, 2002.
DOI : 10.1006/nlme.2002.4099

E. Janssen and C. Palle, Les surdoses mortelles par usage de substances psychoactives en France, Tendances. mai, issue.70, p.4, 2010.

M. Taylor, K. Mackay, J. Murphy, A. Mcintosh, C. Mcintosh et al., Quantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across Scotland, BMJ Open, vol.2, issue.4, p.774, 2012.
DOI : 10.1136/bmjopen-2011-000774

D. Spronk, J. Van-wel, J. Ramaekers, and R. Verkes, Characterizing the cognitive effects of cocaine: A comprehensive review, Neuroscience & Biobehavioral Reviews, vol.37, issue.8, pp.1838-59, 2013.
DOI : 10.1016/j.neubiorev.2013.07.003

K. Soar, C. Mason, A. Potton, and L. Dawkins, Neuropsychological effects associated with recreational cocaine use, Psychopharmacology, vol.64, issue.4, pp.633-676, 2012.
DOI : 10.1001/archpsyc.64.4.495

M. Vonmoos, L. Hulka, K. Preller, F. Minder, M. Baumgartner et al., Cognitive Impairment in Cocaine Users is Drug-Induced but Partially Reversible: Evidence from a Longitudinal Study, Neuropsychopharmacology, vol.73, issue.9, pp.2200-2210, 2014.
DOI : 10.1038/npp.2008.60

A. Romero-martínez and L. Moya-albiol, D??ficits neuropsicol??gicos asociados a la relaci??n entre abuso de coca??na y violencia: mecanismos neuronales facilitadores, Adicciones, vol.27, issue.1, pp.64-74, 2015.
DOI : 10.20882/adicciones.194

D. Jovanovski, S. Erb, and K. Zakzanis, Neurocognitive Deficits in Cocaine Users: A Quantitative Review of the Evidence, Journal of Clinical and Experimental Neuropsychology, vol.16, issue.2, pp.189-204, 2005.
DOI : 10.1093/arclin/16.7.653

B. Lopes, P. Gonçalves, M. Ometto, B. Santos, M. Cavallet et al., Distinct cognitive performance and patterns of drug use among early and late onset cocaine users, Addictive Behaviors, vol.73, pp.41-48, 2017.
DOI : 10.1016/j.addbeh.2017.04.013

M. Milhet, Usages détournés de médicaments psychotropes par les adolescents et jeunes adultes, Rev Litt St-Denis OFDT, 2015.

M. Carrieri, L. Amass, G. Lucas, D. Vlahov, A. Wodak et al., Buprenorphine Use: The International Experience, Clinical Infectious Diseases, vol.43, issue.Supplement 4, pp.197-215, 2006.
DOI : 10.1086/508184

URL : https://academic.oup.com/cid/article-pdf/43/Supplement_4/S197/789536/43-Supplement_4-S197.pdf

J. Emmanuelli and J. Desenclos, Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003, Addiction, vol.91, issue.11, pp.1690-700, 1996.
DOI : 10.1097/00042560-199603010-00010

. Jauffret-roustide, Estimation de la séroprévalence du VIH et de l'hépatite C chez les usagers de drogues en France -Premiers résultats de l'enquête ANRS-Coquelicot, Bull Épidémiologique Hebd, pp.504-513, 2011.

A. Judd, M. Hickman, S. Jones, T. Mcdonald, J. Parry et al., Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study, BMJ, vol.330, issue.7481, pp.24-29, 2005.
DOI : 10.1136/bmj.38286.841227.7C

D. Buchanan, J. Tooze, S. Shaw, M. Kinzly, R. Heimer et al., Demographic, HIV risk behavior, and health status characteristics of ???crack??? cocaine injectors compared to other injection drug users in three New England cities, Drug and Alcohol Dependence, vol.81, issue.3, pp.221-230, 2006.
DOI : 10.1016/j.drugalcdep.2005.07.011

. Public-health-england, Shooting Up: Infections among people who inject drugs in the United Kingdom 2012, nov, 2013.

P. Roux, L. Fugon, J. Jones, and S. Comer, Hepatitis C infection in non-treatment-seeking heroin users: The burden of cocaine injection, The American Journal on Addictions, vol.10, issue.6, pp.613-621, 2013.
DOI : 10.1310/hct1004-215

E. Lloyd-smith, E. Wood, K. Li, J. Montaner, and T. Kerr, Incidence and determinants of initiation into cocaine injection and correlates of frequent cocaine injectors, Drug and Alcohol Dependence, vol.99, issue.1-3, pp.176-82, 2009.
DOI : 10.1016/j.drugalcdep.2008.07.003

J. Macías, R. Palacios, E. Claro, J. Vargas, S. Vergara et al., High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack, Liver International, vol.13, issue.6, pp.781-787, 2008.
DOI : 10.1097/00042560-200208010-00011

C. Fuller, D. Ompad, S. Galea, Y. Wu, B. Koblin et al., Hepatitis C Incidence--a Comparison Between Injection and Noninjection Drug Users in New York City, Journal of Urban Health: Bulletin of the New York Academy of Medicine, vol.81, issue.1, pp.20-24, 2004.
DOI : 10.1093/jurban/jth084

L. Wilkins, P. Bissell, and P. Meier, Risky injecting practices associated with snowballing: A qualitative study, Drug and Alcohol Review, vol.97, issue.3, pp.256-62, 2010.
DOI : 10.4135/9780857020093

S. Williamson, M. Gossop, B. Powis, P. Griffiths, J. Fountain et al., Adverse effects of stimulant drugs in a community sample of drug users, Drug and Alcohol Dependence, vol.44, issue.2-3, pp.2-387, 1997.
DOI : 10.1016/S0376-8716(96)01324-5

B. Laumon and . Gadegbeku, Stupéfiants et accidents mortels (projet SAM) : Analyse épidémiologique, OFDT, vol.166, 2011.

M. Dahan and J. Sauret, Sécurisation du circuit du médicament à l'Assistance Publique- Hôpitaux de Paris (AP-HP). 2010 juillet

M. Cubaynes, D. Noury, M. Dahan, and E. Falip, Le circuit du médicament à l'hôpital, 2011.

J. Calop, S. Limat, and C. Fernandez, Pharmacie clinique et thérapeutique. 4 e éd, 2012.

A. Goris, Centenaire de l'internat en pharmacie des hopitaux et hospices civils de Paris, histoire documentaire de la pharmacie dans les hopitaux et hospices civils de Paris de la révolution à, 1918.

P. Grimbert and . L-'internat-en-pharmacie, L'internat en pharmacie, Bulletin de la Soci??t?? d'histoire de la pharmacie, vol.8, issue.26, pp.195-204, 1920.
DOI : 10.3406/pharm.1920.1361

M. Tatsuno, Histoire de la professionnalisation du pharmacien clinique moderne, Revue d'histoire de la pharmacie, vol.84, issue.312, pp.144-150, 1996.
DOI : 10.3406/pharm.1996.6178

URL : http://www.persee.fr/docAsPDF/pharm_0035-2349_1996_num_84_312_6178.pdf

J. Calop and . La, Pharmacie clinique: pourquoi? Comment? Paris: Éd. Marketing, 1986.

A. Résultats-de-l-'enquête-pharmasud, |. Asud, and . Internet, Disponible sur: http://www.asud.org, 2011.

J. Montastruc, P. Arnaud, C. Barbier, I. Berlin, C. Gatignol et al., Crit??res pharmacologiques d???un m??dicament pour la substitution de la pharmacod??pendance aux opiac??s, Th??rapie, vol.58, issue.2, pp.123-128, 2003.
DOI : 10.2515/therapie:2003017

F. Pelissier, L. Haro, . De, F. Cardona, C. Picot et al., Self-poisoning with baclofen in alcohol-dependent patients: national reports to French Poison Control Centers, 2008???2013, Clinical Toxicology, vol.33, issue.4, pp.275-84, 2008.
DOI : 10.1159/000362409

M. Reynaud, H. Aubin, F. Trinquet, B. Zakine, C. Dano et al., A Randomized, Placebo-Controlled Study of High-Dose Baclofen in Alcohol-Dependent Patients???The ALPADIR Study, Alcohol and Alcoholism, vol.52, issue.4, pp.439-485, 2017.
DOI : 10.1093/alcalc/agx030

J. Liu and L. Wang, Baclofen for alcohol withdrawal In: Cochrane Database of Systematic Reviews, 2017.

P. Bras and A. Kiour, Pharmacies d'officine : rémunération, missions, réseau -IGAS - Inspection générale des affaires sociales. France: IGAS, pp.2011-090, 2011.

O. Brien, M. Anthony, and J. , Risk of Becoming Cocaine Dependent: Epidemiological Estimates for the United States, 2000???2001, Neuropsychopharmacology, vol.26, issue.5, pp.1006-1024, 2000.
DOI : 10.1001/archpsyc.1997.01830160031005

L. Dutra, G. Stathopoulou, S. Basden, T. Leyro, M. Powers et al., A Meta-Analytic Review of Psychosocial Interventions for Substance Use Disorders, American Journal of Psychiatry, vol.165, issue.2, pp.179-87, 2008.
DOI : 10.1176/appi.ajp.2007.06111851

D. Martinez, K. Greene, A. Broft, D. Kumar, F. Liu et al., Receptors Following Acute Dopamine Depletion, American Journal of Psychiatry, vol.166, issue.10, pp.1170-1177, 2009.
DOI : 10.1176/appi.ajp.2009.08121801

D. Martinez, K. Carpenter, F. Liu, M. Slifstein, A. Broft et al., Imaging Dopamine Transmission in Cocaine Dependence: Link Between Neurochemistry and Response to Treatment, American Journal of Psychiatry, vol.168, issue.6, pp.634-675, 2011.
DOI : 10.1176/appi.ajp.2010.10050748

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235735/pdf

J. Mariani and F. Levin, Psychostimulant Treatment of Cocaine Dependence, Psychiatric Clinics of North America, vol.35, issue.2, pp.425-464, 2012.
DOI : 10.1016/j.psc.2012.03.012

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417072/pdf

P. Czoty, R. Gould, J. Martelle, and M. Nader, Prolonged Attenuation of the Reinforcing Strength of Cocaine by Chronic d-Amphetamine in Rhesus Monkeys, Neuropsychopharmacology, vol.95, issue.2, p.539, 2011.
DOI : 10.1007/s00213-003-1409-y

M. Mooney, D. Herin, J. Schmitz, N. Moukaddam, C. Green et al., Effects of oral methamphetamine on cocaine use: A randomized, double-blind, placebo-controlled trial, Drug and Alcohol Dependence, vol.101, issue.1-2, pp.34-41, 2009.
DOI : 10.1016/j.drugalcdep.2008.10.016

M. Greenwald, L. Lundahl, and C. Steinmiller, Sustained Release d-Amphetamine Reduces Cocaine but not ???Speedball???-Seeking in Buprenorphine-Maintained Volunteers: A Test of Dual-Agonist Pharmacotherapy for Cocaine/Heroin Polydrug Abusers, Neuropsychopharmacology, vol.8, issue.13, pp.2624-2661, 2010.
DOI : 10.1124/dmd.31.6.768

C. Rush and W. Stoops, Agonist replacement therapy for cocaine dependence: a translational review, Future Medicinal Chemistry, vol.272, issue.2, pp.245-65, 2012.
DOI : 10.1016/S0149-7634(05)80011-9

L. Karila, M. Reynaud, H. Aubin, R. B. Guardia, D. Cottencin et al., Pharmacological Treatments for Cocaine Dependence: Is There Something New?, Current Pharmaceutical Design, vol.17, issue.14, pp.1359-68, 2011.
DOI : 10.2174/138161211796150873

M. Ferris, E. Calipari, Y. Mateo, J. Melchior, D. Roberts et al., Cocaine Self-Administration Produces Pharmacodynamic Tolerance: Differential Effects on the Potency of Dopamine Transporter Blockers, Releasers, and Methylphenidate, Neuropsychopharmacology, vol.72, issue.7, pp.1708-1724, 2012.
DOI : 10.1016/j.jneumeth.2011.03.001

S. Collins, F. Levin, R. Foltin, H. Kleber, and S. Evans, Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD, Drug and Alcohol Dependence, vol.82, issue.2, pp.158-67, 2006.
DOI : 10.1016/j.drugalcdep.2005.09.003

F. Levin, S. Evans, D. Brooks, and F. Garawi, Treatment of cocaine dependent treatment seekers with adult ADHD: Double-blind comparison of methylphenidate and placebo, Drug and Alcohol Dependence, vol.87, issue.1, pp.20-29, 2007.
DOI : 10.1016/j.drugalcdep.2006.07.004

R. Goldstein and N. Volkow, Oral Methylphenidate Normalizes Cingulate Activity and Decreases Impulsivity in Cocaine Addiction During an Emotionally Salient Cognitive Task, Neuropsychopharmacology, vol.20, issue.1, pp.366-373, 2011.
DOI : 10.1371/journal.pone.0002017

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055523/pdf

N. Volkow, G. Wang, D. Tomasi, F. Telang, J. Fowler et al., Methylphenidate Attenuates Limbic Brain Inhibition after Cocaine-Cues Exposure in Cocaine Abusers, PLoS ONE, vol.2, issue.4, p.11509, 2010.
DOI : 10.1371/journal.pone.0011509.s001

URL : https://doi.org/10.1371/journal.pone.0011509

A. Konova, S. Moeller, D. Tomasi, N. Volkow, and R. Goldstein, Effects of Methylphenidate on Resting-State Functional Connectivity of the Mesocorticolimbic Dopamine Pathways in Cocaine Addiction, JAMA Psychiatry, vol.70, issue.8, pp.857-68, 2013.
DOI : 10.1001/jamapsychiatry.2013.1129

T. Winhusen, E. Somoza, B. Singal, J. Harrer, S. Apparaju et al., Methylphenidate and cocaine: A placebo-controlled drug interaction study, Pharmacology Biochemistry and Behavior, vol.85, issue.1, pp.29-38, 2006.
DOI : 10.1016/j.pbb.2006.06.023

V. Lp, 40 mg gél LP -Indications [Internet] Disponible sur: https://www.vidal.fr/Medicament/ritaline_lp-20546-indications.htm 101

A. Mclellan, L. Luborsky, J. Cacciola, J. Griffith, F. Evans et al., New Data from the Addiction Severity Index Reliability and Validity in Three Centers, The Journal of Nervous and Mental Disease, vol.173, issue.7, pp.412-435, 1985.
DOI : 10.1097/00005053-198507000-00005

C. Denis, M. Fatséas, V. Beltran, F. Serre, J. Alexandre et al., Usefulness and validity of the modified Addiction Severity Index: A focus on alcohol, drugs, tobacco, and gambling, Subst Abuse. 2 janv, pp.168-75, 2016.
DOI : 10.1016/j.jsat.2013.06.003

C. Fry and N. Lintzeris, Psychometric properties of the Blood-borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ). Addiction. 1 févr, pp.171-179, 2003.

L. Karila, E. Seringe, A. Reynaud, and M. , The Reliability and Validity of the French Version of the Cocaine Craving Questionnaire-Brief. Current Pharmaceutical Design, 2011.

L. Radloff, C. The, and . Scale, The CES-D Scale, Applied Psychological Measurement, vol.12, issue.3, pp.385-401, 1977.
DOI : 10.1001/archpsyc.1965.01720310065008

J. Bernaud, Introduction à la psychométrie. Paris: Dunod, 2007.

M. Carrieri, P. Roux, J. Cohen, I. Ravaux, P. Dellamonica et al., Self-reported side effects in buprenorphine and methadone patients receiving antiretroviral therapy: results from the MANIF 2000 cohort study, Addiction, vol.20, issue.Suppl 1, pp.2160-2168, 2010.
DOI : 10.3109/10826088709027454

S. Comer, J. Ashworth, R. Foltin, C. Johanson, J. Zacny et al., The role of human drug self-administration procedures in the development of medications, Drug and Alcohol Dependence, vol.96, issue.1-2, pp.1-15, 2008.
DOI : 10.1016/j.drugalcdep.2008.03.001

H. Deery and A. Love, The Driving Expectancy Questionnaire: development, psychometric assessment and predictive utility among young drink-drivers., Journal of Studies on Alcohol, vol.57, issue.2, pp.193-202, 1996.
DOI : 10.15288/jsa.1996.57.193

M. Morean, H. De-wit, A. King, M. Sofuoglu, S. Rueger et al., The drug effects questionnaire: psychometric support across three drug types, Psychopharmacology, vol.112, issue.1, pp.177-92, 2013.
DOI : 10.1016/j.drugalcdep.2010.06.008

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624068/pdf

A. King, H. De-wit, P. Mcnamara, and D. Cao, Rewarding, Stimulant, and Sedative Alcohol Responses and Relationship to Future Binge Drinking, Archives of General Psychiatry, vol.68, issue.4, p.389, 2011.
DOI : 10.1001/archgenpsychiatry.2011.26

URL : https://jamanetwork.com/journals/jamapsychiatry/articlepdf/211208/yoa05079_389_399.pdf

S. Reed, F. Levin, and S. Evans, Alcohol increases impulsivity and abuse liability in heavy drinking women., Experimental and Clinical Psychopharmacology, vol.20, issue.6, pp.454-65, 2012.
DOI : 10.1037/a0029087

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598581/pdf

S. Evans and F. Levin, The effects of alprazolam and buspirone in light and moderate female social drinkers, Behavioural Pharmacology, vol.13, issue.5, pp.427-439, 2002.
DOI : 10.1097/00008877-200209000-00016

A. Dlugos, A. Hamidovic, C. Hodgkinson, P. Shen, D. Goldman et al., OPRM1 gene variants modulate amphetamine-induced euphoria in humans, Genes, Brain and Behavior, vol.2, issue.2, pp.199-209, 2011.
DOI : 10.1038/nm1196-1225

URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1601-183X.2010.00655.x/pdf

S. Evans and A. Bisaga, Acute Interaction of Baclofen in Combination With Alcohol in Heavy Social Drinkers, Alcoholism: Clinical and Experimental Research, vol.33, issue.1, pp.19-30, 2009.
DOI : 10.1161/01.HYP.37.5.1199

S. Comer, M. Sullivan, and E. Walker, Comparison of Intravenous Buprenorphine and Methadone Self-Administration by Recently Detoxified Heroin-Dependent Individuals, Journal of Pharmacology and Experimental Therapeutics, vol.315, issue.3, pp.1320-1350, 2005.
DOI : 10.1124/jpet.105.090423

S. Comer, E. Walker, and E. Collins, Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers, Psychopharmacology, vol.35, issue.2, pp.664-75, 2005.
DOI : 10.1176/ajp.151.7.1025

B. Johnson, J. Roache, N. Ait-daoud, C. Wallace, L. Wells et al., Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine's subjective and reinforcing effects, The International Journal of Neuropsychopharmacology, vol.8, issue.2, pp.203-216, 2005.
DOI : 10.1017/S1461145704005036

L. Webster, F. Johnson, J. Stauffer, B. Setnik, and S. Ciric, Impact of Intravenous Naltrexone on Intravenous Morphine-Induced High, Drug Liking, and Euphoric Effects in Experienced, Nondependent Male Opioid Users, Drugs in R&D, vol.10, issue.2, p.259, 2011.
DOI : 10.1016/j.jpain.2008.10.008

M. Sofuoglu, A. Herman, Y. Li, and A. Waters, Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report, Psychopharmacology, vol.223, issue.3, pp.413-433, 2012.
DOI : 10.1016/j.bbr.2011.04.010

C. Hamilton, L. Strader, J. Pratt, D. Maiese, T. Hendershot et al., The PhenX Toolkit: Get the Most From Your Measures, American Journal of Epidemiology, vol.174, issue.3, pp.253-60, 2011.
DOI : 10.1093/aje/kwr193

URL : https://academic.oup.com/aje/article-pdf/174/3/253/684923/kwr193.pdf

A. Elkader, B. Brands, R. Callaghan, and B. Sproule, Exploring the relationship between perceived inter-dose opioid withdrawal and patient characteristics in methadone maintenance treatment, Drug and Alcohol Dependence, vol.105, issue.3, pp.209-223, 2009.
DOI : 10.1016/j.drugalcdep.2009.07.003

A. Rubinsky, D. Dawson, E. Williams, D. Kivlahan, and K. Bradley, AUDIT-C Scores as a Scaled Marker of Mean Daily Drinking, Alcohol Use Disorder Severity, and Probability of Alcohol Dependence in a U.S. General Population Sample of Drinkers, Alcoholism: Clinical and Experimental Research, vol.25, issue.8, pp.1380-90, 2013.
DOI : 10.1037/a0022102

R. J. Mokken, A Theory and Procedure of Scale Analysis : With Applications in Political Research. Mouton: De Gruyter, 1971.
DOI : 10.1515/9783110813203